SEC Comment Letter for CarbonMeta Technologies, Inc. (CIK 0001156784) — Oct 28, 2005
CarbonMeta Technologies, Inc. (CIK 0001156784)
Date: Oct. 28, 2005 · CIK: 0001156784 · Accession: 0000000000-05-054841
AI Filing Summary & Sentiment
File numbers found in text: 333-127368
Referenced dates: October 12, 2005, October 12, 2005, September 2, 2005
Show Raw Text
<DOCUMENT>
<TYPE>LETTER
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
October 28, 2005
Room 4561
Walter K. Weisel
Chief Executive Officer
Innova Holdings, Inc.
17105 San Carlos Boulevard, Suite A1651
Fort Myers, Florida 33931
Re: Innova Holdings, Inc.
Supplemental Response Concerning Registration Statement on
Form
SB-2/A
Filed September 30, 2005, Submitted on October 17, 2005
File No. 333-127368
Form 10-KSB/A for Fiscal Year Ended December 31, 2004
Filed on July 29, 2005
Form 10-QSB/A for Fiscal Quarter Ended March 31, 2005
Filed on July 29, 2005
Form 10-QSB for Fiscal Quarter Ended June 30, 2005
Filed on August 22, 2005
Form 8-K filed on October 19, 2005
File No. 0-33231
Dear Mr. Weisel:
This is to advise you that we have limited our review of the
above-referenced documents to the responses to our comment letter
dated October 12, 2005 and other matters addressed in the comments
below. Please respond to our comments that pertain to the Form
10-
KSB/A, Form 10-QSB/A, Form 10-QSB and Form 8-K within 10 business
days of the date of this letter.
Registration Statement on Form SB-2, as amended
Prospectus Cover Page
1. We refer you to comment 1 of our letter dated October 12, 2005.
Please revise to state if true, Cornell Capital Partners is an
underwriter as opposed to "is deemed" an underwriter. Please
advise
why you believe Monitor Capital and the selling shareholders to be
underwriters; we note that Monitor is reselling shares received as
transaction-based compensation. Please also remove the sentence
that follows or supplementally support the statement.
Risk Factors page 5
2. We refer you to comment 2 of our letter dated October 12, 2005.
Please clarify whether your disclosure controls and procedures are
currently effective. To the extent that they are currently
ineffective, please describe any material risks to potential
investors. Further, with respect to your controls and procedures
it
appears that your Form 8-K, filed October 19, 2005, may have been
filed late. Please advise.
Selling Stockholders, page 13
3. We note your response to comment 3 of our letter dated October
12,
2005. It appears from information available on Cornell Capital
Partners website and from your Placement Agent Agreement that
Cornell
Capital Partners West Coast office and Monitor Capital share the
same
suite in San Diego. Please tell us whether Cornell Capital or any
equity owners, officers or directors of Cornell Capital hold
equity
interests in Monitor Capital. Please describe any such ownership
interests in Monitor Capital.
4. Further, we refer you to comment 2 of our letter dated
September
2, 2005. Please describe more fully the specific services
performed
by Monitor as your placement agent, including a discussion of the
actions taken as part of the review and advice process. Please
also
advise as the timing of their review and value of services since
we
note that the Placement Agent Agreement was entered into the same
day
as the Standby Equity Distribution Agreement (June 14, 2005). In
this regard, your Form SB-2 disclosure notes that the purpose of
entering into a private placement agreement with Monitor was to
"advise the Company with respect to the terms" of the equity line
agreement, however, both agreements were signed the same day.
Supplemental response with proposed revisions to your Form 10-
KSB/A
for the fiscal year ended December 31, 2004 filed on July 29, 2005
and submitted on October 17, 2005
5. We refer you to your response to comment 6 of our letter dated
October 12, 2005. While we note your intent to update your
"Management`s Discussion and Analysis or Plan of Operation"
section
as costs are incurred, please ensure to include in your "Liquidity
and Capital Resources" subsection in the Form 10-QSB for the
quarter
ended September 30, 2005, if applicable, a discussion of how
material
costs associated with your remediation measures may effect your
liquidity. Please also revise the above-referenced Form SB-2 as
well.
Supplemental response with proposed revisions to your Form 10-QSB
for
the fiscal quarter ended June 30, 2005 filed August 22, 2005 and
submitted on October 17, 2005
6. We note your response to comment 9 of our letter dated October
12,
2005 that states there were changes in your internal controls over
financial reporting that occurred during the last fiscal quarter
that
materially affected, or is reasonably likely to materially affect
your internal control over financial reporting. However, your
revised disclosure discusses only "remedial actions, " relating to
your material weakness. Please confirm there were no changes
besides
remedial measures disclosed that materially affected, or are
reasonably likely to materially affect your internal control over
financial reporting.
Form 8-K filed October 19, 2005
7. Please revise your Form SB-2 including your "Selling
Stockholders," "Management`s Discussion and Analysis or Plan of
Operation" and "Certain Relationships and Related Transactions"
sections to incorporate the information contained in this Form 8-
K.
Please ensure to prominently describe the fact that the Company
will
pay to Cornell all revenues it receives until the principal and
accrued interest has been paid in full.
8. We note that you filed this Form 8-K on October 19, 2005 for a
reportable event that took place on October 7, 2005. Please
advise
as to your belief of the timeliness of this filing.
9. Please advise as to the closing date of the financing related
to
the Cornell Capital private placement discussed in this 8-K.
Please
also confirm that as of that date all funds were released from
escrow
and that there are no further obligations of the Escrow Agent.
* * *
If you have any questions, please contact Adam Halper at
(202)
551-3482. If you need additional assistance you may contact me at
(202) 551-3730.
Sincerely,
Barbara C. Jacobs
Assistant Director
cc: Robert L. Davidson, Esq.
400 Park Avenue, Suite 1430
New York, NY 10022
Fax: (212) 277-7401
??
??
??
??
Walter K. Weisel
Innova Holdings, Inc.
October 28, 2005
Page 1
</TEXT>
</DOCUMENT>